Proteasome inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Proteasome inhibitor, covering 2025-07-09 to 2025-07-09. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]